CD8A and neoplasm: Using an EL4-ova subcutaneous model system to permit tracking of immune responses, we observed that DGKζ−/− mice had an increased frequency of tumor rejection, along with a trend toward increased number of tumor-specific CD8+ T cells (Riese et al., 2011).